Acute myocardial infarction in young patients: etiology, risk factors, genetics

Česká verzia

Authors: O. Toman
Authors place of work: Interní kardiologická klinika LF MU a FN Brno, pracoviště Bohunice
Published in the journal: Kardiol Rev Int Med 2006, 8(1-2): 27-31
Category: Editorial

Summary

Acute myocardial infarction (AMI) belongs to the most serious diagnoses of an epidemy of cardiovascular diseases. It affects in lower percentage even younger individuals. Aetiology of coronary occlusion in young patients is different from the usual scenario of coronary atherogenesis. Even individuals with angiographically normal coronary arteries are affected with AMI. specific risk factors including primary thrombophilia, genetic influences were documented. The most frequent cause of AMI in patients with macroscopic affection of coronary arteries is premature accelarated atherosclerosis. Short-term prognosis of these patients treated with primary coronary intervention is good. However, data on long-term prognosis are missing. Only small groups of young AMI patients from the 8th and 9th decade of 20th century were described and these patients were treated mainly conservatively or with thrombolysis. This paper summarizes the most frequent causes and risk factors of AMI in young patients including thrombophilias associated with arterial thrombosis and up to date known genetic disorders in the pathways of coronary atherogenesis and thrombosis.

Key words:
myocardial infarction – coronary artery disease - age – genetic risk - thrombophilia

Zdroje

1. Beta-blocker Heart Attack Trial Research Group. A Randomized Trial of Propranolol in Patients With Acute Myocardial Infarction. JAMA 1982; 247(12): 1707-1714.

2. GUSTO investigators. An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction. NEJM 1993; 329: 673-682.

3. TIMI study group. Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction. NEJM 1989; 320: 618-627.

4. Choudhury L, Marsh JD. Myocardial infartion in young patients. Am J Med 1999; 107: 254-261.

5. Osula S, Bell GM, Hornung RS. Acute myocardial infarction in young adults: causes and management. Postgrad Med J 2002; 78: 27-30.

6. Williams MJA, Restieaux NJ, Low CJS. Myocardial infarction in young people with normal coronary arteries. Heart 1998; 79: 191-194.

7. Ammann P, Marschall S, Kraus M et al. Characteristics and Prognosis of Myocardial Infarction in Patients With Normal Coronary Arteries. Chest 2000; 117: 333-338.

8. Baštecký J, Dulíček P, Kvasnička J. Hyperkoagulační stav u akutních koronárních syndromů. Stručný přehled problematiky očima klinika. Cor Vasa 2003; 45(6): 323-327.

9. Morton KL, Gavaghan TP, Krilis SA et al. Coronary artery bypass grafting failure: an autoimmune phenomenon? Lancet 1986; 2: 977-978.

10. Hopkins PN, Hunt SC, Schreiner PJ. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease. Results from the NHLBI Family Heart Study. Atherosclerosis 1998; 141: 333-345.

11. Booth GL, Wang E with the Canadian Task Force on Preventive Health Care. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. CMAJ 2000; 163: 21-29.

12. Ma J, Stampfer MI, Hennekens CH et al. The methylentetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations. Atherosclerosis 2000; 153: 161-168.

13. Žák A. Homocystein. In: Aschermann M et al. Kardiologie. Praha: Galén 2004.

14. Van de Water NS, French JK, Lund H et al. Prevalence of Factor Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol. 2000; 36: 717-722.

15. Mansourati J, Da Costa A, Munier S et al. Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost 2000; 83: 822-825.

16. Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. NEJM 1997; 336: 973-979.

17. Van Cott EM, Lasposta M, Prins MH. Laboratory Evaluation of Hypercoagulability With Venous or Arterial Thrombosis. Arch Pathol Lab Med 2002; 126: 1281-1295.

18. Mohanty D, Ghosh K, Khare A et al. Thrombophilia in Coronary Artery Disease: A double jeopardy. Indian J Med Res 2004; 120: 13-23.

19. Mc Gill HC, McMahan CA, Zieske AW et al. Association of coronary heart disease with microscopic qualities of coronary atherosclerosis in youth. Circulation 2000; 102: 375.

20. Hennekens C, Evans D, Peto R. Oral contraceptive use, cigarette smoking and myocardial infarction. Br J Fam Plann 1989; 5: 66-67.

21. Marenberg ME, Risch N, Berkman LF et al. Genetic susceptibility to death from coronary heart disease in a study of twins. NEJM 1994; 330: 1041-1046.

22. Chaer RA, Billeh R, Massad MG. Genetics and Gene Manipulation Therapy of Premature Coronary Artury Disease. Cardiology 2004; 101: 122-130.

23. Kraus WE. Genetic approaches for the investigation of genes associated with coronary heart disease. Am Heart J 2000; 140: 527-535.

24. Novotný T. Molekulárně genetické aspekty v arytmologii. Vnitř Lék 2003; 49: 768-772.

25. National Center for Biotechnology Information. OMIM: Online Mendelian Inheritance in man. 143890 hypercholesterolemia, familial. www.ncbi.nlm.nih.gov/omim/

26. Hořínek A, Češka R, Šobra J et al. Familial defective apolipoprotein B-100 homozygote with premature coronary atherosclerosis. A case report. J Int Med 1999; 246: 235-236.

27. Cambien F, Poirer O, Lecerf L et al. Deletion polymorphism in the angiotensi-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.

28. Doughty M, Mehta R, Bruckman D et al. Acute myocardial infarction in the young-The University of Michigan experience. Am Heart J 2002; 143: 56-62.

29. Kofflard MJ, de Jaegere PP, van Domburg R at al. Immediate and long-term clinical outcome of coronary angioplasty in patients aged 35 years or less. British Heart Journal 1995; 73: 82-86.

30. Awad-Elkarim AA,Bagger JP, Alberts CJ et al. A prospective study of long term prognosis in young myocardial infarction survivors: the prognostic value of angiography and exercise testing. Heart 2003; 89: 843-847.

31. Raymond R, Lych J, Underwood D, Leatherman J et al. Myocardial infarction and normal coronary arteriography: a 10 year clinical and risk analysis of 74 patients. J Am Coll Cardiol 1988; 11: 471-477.

32. Pecora MJ, Roubin GS, Cobss BW et al. Presentation and late outcome of myocardial infarction in the absence of angiographically significant coronary artery disease. Am J Cardiol 1988; 62: 363-367.

33. Cole JH, Miller JI, Sperling LS et al. Long-Term Follow-Up of Coronary Artery Disease Presenting in Young Adults. JACC 2003; 41(4): 521-528.